Author

W. Juying

Observed name: JuYing Wei

Institutions: First Affiliated Hospital Zhejiang University, Zhejiang University

Observed institutions: First Affiliated Hospital Zhejiang University, Zhejiang University

OpenAlex ID: A5000614752

Covalent Bruton’s tyrosine kinase inhibitor HZ-A-018 in patients with relapsed or refractory B cell malignancies: A multicenter phase I study

2026 · Guolan Wu, JuYing Wei, et al. · iScience

Pcn99 the Cost-effectiveness and Budget Impact Analysis of Rituximab(hanlikang) for Patients With Diffuse Large B-cell Lymphoma in China

2019 · M.M. Zhao, Y. Xiang, et al. · Value in Health

Works count: 2

Citation count:

H-index:

I10-index: